Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography.
about
Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs.The subaortic tendon as a mimic of hypertrophic cardiomyopathyThe mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease.Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.Myocardial Deformation in Cardiac Amyloid Light-chain Amyloidosis: Assessed with 3T Cardiovascular Magnetic Resonance Feature Tracking.Guideline of transthyretin-related hereditary amyloidosis for clinicians.Impact of regional left ventricular function on outcome for patients with AL amyloidosis.Subclinical echocardiographic abnormalities in phenotype-negative carriers of myosin-binding protein C3 gene mutation for hypertrophic cardiomyopathy.Transthyretin cardiac amyloidoses in older North Americans.Updates in cardiac amyloidosis: a review.Transthyretin (TTR) cardiac amyloidosis.Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile FunctionTransthyretin Cardiac Amyloidosis in Black AmericansCardiac involvement in hereditary-transthyretin related amyloidosis.Cardiac toxicity of anticancer agents.Almanac 2014: cardiovascular imaging.Improving strategies for the diagnosis of cardiac amyloidosis.Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography.Use of Noninvasive Imaging in Cardiac Amyloidosis.Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.Recent advances in the noninvasive strategies of cardiac amyloidosis.Strain Imaging Echocardiography: What Imaging Cardiologists Should Know.Two- and three-dimensional speckle tracking echocardiography: clinical applications and future directions.Quantification of global myocardial function by cine MRI deformable registration-based analysis: Comparison with MR feature tracking and speckle-tracking echocardiography.Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis.The relative impact of circumferential and longitudinal shortening on left ventricular ejection fraction and stroke volumeSpeckle Tracking and Transthyretin Amyloid Cardiomyopathy.Feature tracking compared with tissue tagging measurements of segmental strain by cardiovascular magnetic resonance.Severe Left Ventricular Hypertrophy, Small Pericardial Effusion, and Diffuse Late Gadolinium Enhancement by Cardiac Magnetic Resonance Suspecting Cardiac Amyloidosis: Endomyocardial Biopsy Reveals an Unexpected DiagnosisTransthyretin Cardiac Amyloidosis.Evaluation of patients with cardiac amyloidosis using echocardiography, ECG and right heart catheterization.Characteristic systolic waveform of left ventricular longitudinal strain rate in patients with hypertrophic cardiomyopathy.Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study.Utility of strain-echocardiography in current clinical practice.Comparison of the standard and speckle tracking echocardiographic features of wild-type and mutated transthyretin cardiac amyloidoses.Comparison of right ventricular contractile abnormalities in hypertrophic cardiomyopathy versus hypertensive heart disease using two dimensional strain imaging: a cross-sectional study.The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis.Early Impairment of Cardiac Function and Asynchronization of Systemic Amyloidosis with Preserved Ejection Fraction Using Two-Dimensional Speckle Tracking Echocardiography.Four-Dimensional Speckle Tracking Echocardiography in Patients with Hypertrophic Cardiomyopathy.The prognostic value of standardized reference values for speckle-tracking global longitudinal strain in hypertrophic cardiomyopathy.
P2860
Q30427656-442FD4FE-4F2C-4258-A3A5-E7EBF372CC9FQ30488969-94ED2688-B742-4358-9332-6B397DF69044Q30847650-D658CE6E-4F86-4BE8-B8E0-DA4EDF1430CCQ33763883-249ABDFA-45EA-4149-8C0B-999CD5D627DBQ33812497-EBF03771-47D3-4BE0-8FA6-BB587C3A0637Q34328734-EA78359B-D2D6-47B4-8D74-397D85D9904FQ34631654-3C7A56E2-9319-443E-8672-875F0F23D9EDQ35163739-7A34330A-521D-41CE-8100-117EE787B30AQ35886169-1D20B5E3-F157-4459-88CE-0098713598CFQ36366356-C120EB13-9806-4782-BB0A-73FE3CABF464Q36408438-5D9688C6-7F7F-44EE-B907-4E899C0AA0FCQ36625788-F7C7E2BD-0D7A-4CD4-A9F7-C0B7CFDDED1EQ36921392-32D9B7A0-8ED4-464C-8D19-5AC52032837CQ38001756-480DE1DF-CC2C-4AB9-A3DF-CD52130DB4B0Q38091377-68C1ACD3-61CD-4003-8F5E-05C794B4BF7BQ38259214-CA8ACB4A-2566-4BAA-9873-30282C33581FQ38547033-99902F23-FA77-429C-BC83-8A2410EC1ED2Q38791718-54336FA5-A7DB-4322-97C9-92436C136708Q38834998-52289936-9341-4F84-AC26-DB99D44057BAQ38869625-D5F4FD2C-E236-45B7-9B20-D4EB438454F9Q38935425-8A5CEF28-D40C-4DDB-9C1D-DE0287EA2FC9Q38995468-BF91DA9E-55A8-4A14-B682-A2AB530A3AB4Q39489758-E9C53E80-47CD-4DDD-94B8-F534DE7A58D9Q39523755-72366EFA-D8F4-43E2-A270-A13E98A386EEQ41582133-509BD6A7-D95E-4545-9DA1-35BE897F57CDQ41874093-DD939F83-412F-4603-A07E-A2B8BF1483ECQ41946701-A6404CAF-7C4D-4E5C-A4DF-97316700CD9AQ41960856-7B5EF024-4749-41C4-8EBC-95109AE40F5FQ42247355-53D0BAD2-8907-40C0-9071-4790E4785C1FQ45065991-3C631B70-D2C4-4218-ABBF-188DC3A21AABQ45844390-CBEDCE57-A6F3-4063-9F8F-4BBAF1DE861CQ48592920-394DDF36-CEDF-4B06-8770-522D980F5E23Q48611676-5DC4653B-1A6D-4BE4-99B9-C8B7E12E162CQ48625724-110EAC2B-7B20-4A4A-8ACD-4C8F2957BDDFQ48628498-FBB3B024-46B7-409E-84C1-C923127B4AE4Q48657853-303B3BAF-065C-4086-97B3-60E3559CAFFBQ48660637-0D500A94-6FE8-4434-BB1A-9163560CE0EEQ48667105-63CDE1C7-D3CB-49C7-B916-917D360524C1Q48682173-F3615DBC-7F4E-415D-8E17-E32753FC01DCQ48689568-75D26245-7EE5-4D69-8FE6-334DEB91D340
P2860
Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Differentiation of hypertrophi ...... rain imaging echocardiography.
@en
Differentiation of hypertrophi ...... rain imaging echocardiography.
@nl
type
label
Differentiation of hypertrophi ...... rain imaging echocardiography.
@en
Differentiation of hypertrophi ...... rain imaging echocardiography.
@nl
prefLabel
Differentiation of hypertrophi ...... rain imaging echocardiography.
@en
Differentiation of hypertrophi ...... rain imaging echocardiography.
@nl
P2093
P1476
Differentiation of hypertrophi ...... rain imaging echocardiography.
@en
P2093
Angel R Leon
James D Thomas
Jing Ping Sun
Joel M Felner
John D Merlino
Robert O Donnell
William J Stewart
Xing Sheng Yang
P304
P356
10.1016/J.AMJCARD.2008.09.102
P407
P577
2008-11-27T00:00:00Z